Skip to content

Clinical significance of preserving the vagus nerve during thoracoscopic radical resection of lung cancer: a randomized controlled trial

Clinical significance of preserving the vagus nerve during thoracoscopic radical resection of lung cancer: a randomized controlled trial

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1900021367
Enrollment
Unknown
Registered
2019-02-17
Start date
2019-03-01
Completion date
Unknown
Last updated
2019-02-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lung Cancer

Interventions

Group 1:dissociate Vagus nerve
Group 2:don‘t dissociate Vagus nerve

Sponsors

West China Hospital, Sichuan University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Aged 18 to 75 years; 2. Pathological results are primary lung cancer; 3. Thoracoscopic lobectomy or segmentectomy and systemic lymph node dissection.

Exclusion criteria

Exclusion criteria: 1. Drug therapy was given for cough within two weeks before operation, and abdominal distension, diarrhea and constipation were found 3 months before operation; 2. Opening the chest during the operation and the amount of bleeding is more than 1000 ml; 3. Second operation, simultaneous bilateral operation and total pneumonectomy for lung cancer; 4. Severe thoracic adhesions, direct invasion of tumors, lymphadenopathy and vagal nerve dissection are not clearly demarcated; 5. Disagree with Participating Researchers.

Design outcomes

Primary

MeasureTime frame
Postoperative symptoms;Postoperative pain;Postoperative cough;Evaluation postoperativeof gastrointestinal function;

Countries

China

Contacts

Public ContactGuowei Che
guowei_che@yahoo.com+86 18980601890

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026